Identification of dihydrotanshinone I as an ERp57 inhibitor with anti-breast cancer properties via the UPR pathway

This publication has 36 references indexed in Scilit:

• The protein ERp57 contributes to EGF receptor signaling and internalization in MDA-MB-468 breast cancer cells
  Journal of Cellular Biochemistry, 2013
• Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
  Proceedings of the National Academy of Sciences, 2012
• The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis
  Blood, 2012
• The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
  Science, 2011
• Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells
  Experimental Cell Research, 2010
• Insights into MHC Class I Peptide Loading from the Structure of the Tapasin-ERp57 Thiol Oxidoreductase Heterodimer
  Immunity, 2009
• In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases
  Physiological Reviews, 2007
• Simultaneous determination of abietane-type diterpenes, flavonolignans and phenolic compounds in compound preparations of Silybum marianum and Salvia miltiorrhiza by HPLC-DAD-ESI MS
  Journal of Pharmaceutical and Biomedical Analysis, 2005
• The evolving role of natural products in drug discovery
  Nature Reviews Drug Discovery, 2005
• ER stress and the unfolded protein response
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005